China’s biotech surge sparks US security concerns as drug trials break records in 2025

💲 Paywalled: This content may require a subscription. Manage paywalled content settings on Scour.

Clinical drug trial registrations in China hit a record last year, the country’s drug regulator said, with more than 5,000 trials reported in the latest sign of the nation’s growing pipeline of novel drug candidates. The total number of clinical drug trials reached 5,215 in 2025, more than double th…

View Post on Scour ↗

More from South China Morning Post on Scour.